首页> 外国专利> PERIPHERAL BLOOD TCR MARKER FOR PROSTATE CANCER, AND DETECTION KIT AND USE THEREOF

PERIPHERAL BLOOD TCR MARKER FOR PROSTATE CANCER, AND DETECTION KIT AND USE THEREOF

机译:前列腺癌的外周血TCR标志物,以及检测试剂盒及其用途

摘要

Provided are a peripheral blood TCR marker for prostate cancer, and a detection kit and the use thereof. The marker comprises at least one of the proteins as shown in SEQ ID NOs: 1-100. On the basis of a high-throughput sequencing method, only a small amount of peripheral blood needs to be collected for extracting RNA. An immune map library is established by means of processing samples, and then by means of high-throughput sequencing and TCR data analysis, firstly, a characteristic TCR sequence in the peripheral blood of prostate cancer is determined, and then the test results of a sample to be tested are compared with the characteristic TCR sequence so as to determine whether someone has prostate cancer. By means of the method, a large number of prostate cancer specific TCR sequences can be simultaneously compared, and the method has higher specificity and accuracy compared with the independent detection of one or several markers, thereby improving the diagnosis efficiency.
机译:提供用于前列腺癌的外周血TCR标志物,以及检测试剂盒及其用途。 标记物包含至少一种蛋白质,如SEQ ID NO:1-100所示。 在高通量测序方法的基础上,仅需要收集少量外周血以提取RNA。 通过处理样品建立免疫图库,然后通过高通量测序和TCR数据分析,首先确定前列腺癌外周血中的特征TCR序列,然后是样品的测试结果 将测试与特征TCR序列进行比较,以确定有人是否具有前列腺癌。 借助于该方法,比较大量前列腺癌特异性TCR序列,与一个或多个标记的独立检测相比,该方法具有更高的特异性和准确性,从而提高了诊断效率。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号